Pharmacotherapy of trichotillomania (hair pulling disorder): an updated systematic review

Bibliography

• Christenson GA, Pyle RL, Mitchell JE. Estimated lifetime prevalence of trichotillomania in college students. J Clin Psychiatry 1991;52:415-17
   PubMed Web of Science ®Google Scholar
• Rothbaum BO, Shaw L, Morris R, Ninan PT. Prevalence of trichotillomania in a college freshman population. J Clin Psychiatry 1993;54:72-3
   PubMed Web of Science ®Google Scholar
• Stein DJ, Grant JE, Franklin ME, et al. Trichotillomania (hair pulling disorder), skin picking disorder, and stereotypic movement disorder: toward DSM-V. Depress Anxiety 2010;27:611-26
   PubMed Web of Science ®Google Scholar
• Van Ameringen M, Patterson B, Simpson W. DSM-5 obsessive-compulsive and related disorders: clinical implications of new criteria. Depress Anxiety 2014;31:487-93
   PubMed Web of Science ®Google Scholar
• Chamberlain SR, Menzies LA, et al. Grey matter abnormalities in trichotillomania: morphometric magnetic resonance imaging study. Br J Psychiatry 2008;193:216-21
   PubMed Web of Science ®Google Scholar
• White MP, Shirer WR, Molfino MJ, et al. Disordered reward processing and functional connectivity in trichotillomania: a pilot study. J Psychiatr Res 2013;47:1264-72
   Web of Science ®Google Scholar
• Stein DJ, van Heerden B, Hugo C, et al. Functional brain imaging and pharmacotherapy in trichotillomania single photon emission computed tomography before and after treatment with the selective serotonin reuptake inhibitor citalopram. Prog Neuropsychopharmacol Biol Psychiatry 2002;26:885-90
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-V. American Psychiatric Association, Washington DC; 2013
   Google Scholar
• Rothbart R, Amos T, Siegfried N, et al. Pharmacotherapy for trichotillomania. Cochrane Database Syst Rev 2013(11):CD007662
   Google Scholar
• Christenson GA, Mackenzie TB, Mitchell JE, Callies AL. A placebo-controlled, double-blind crossover study of fluoxetine in trichotillomania. Am J Psychiatry 1991;148:1566-71
   PubMed Web of Science ®Google Scholar
• Streichenwein SM, Thornby JI. A long-term, double- blind, placebo-controlled crossover trial of the efficacy of fluoxetine for trichotillomania. Am J Psychiatry 1995;152:1192-6
   PubMed Web of Science ®Google Scholar
• Dougherty DD, Loh R, Jenike MA, Keuthen NJ. Single modality versus dual modality treatment for trichotillomania: sertraline, behavioral therapy, or both? J Clin Psychiatry 2006;67:1086-92
   PubMed Web of Science ®Google Scholar
• Van Minnen A, Hoogduin KAL, Keijsers GPJ, et al. Treatment of trichotillomania with behavioral therapy or fluoxetine. Arch Gen Psychiatry 2003;60:517-22
   PubMed Web of Science ®Google Scholar
• Stanley MA, Breckenridge JK, Swann AC, et al. Fluvoxamine treatment of trichotillomania. J Clin Psychopharmacol 1997;17:278-83
   PubMed Web of Science ®Google Scholar
• Stein DJ, Bouwer C, Maud CM. Use of the selective serotonin reuptake inhibitor citalopram in treatment of trichotillomania. Eur Arch Psychiatry Clin Neurosci 1997;247:234-6
   PubMed Web of Science ®Google Scholar
• Ninan PT, Rothbaum BO, Marsteller FA, et al. A placebo-controlled trial of cognitive-behavioral therapy and clomipramine in trichotillomania. J Clin Psychiatry 2000;61:47-50
   PubMed Web of Science ®Google Scholar
• Swedo SE, Leonard HL, Rapoport JL, et al. A double-blind comparison of clomipramine and desipramine in the treatment of trichotillomania (hair pulling). N Engl J Med 1989;321:497-501
   PubMed Web of Science ®Google Scholar
• Christenson GA, Crow SJ, Mackenzie TB, et al. A placebo controlled double-blind study of naltrexone for trichotillomania [abstract NR597]. American Psychiatric Assocation Annual Meeting; Philadelphia: APA; 1994. p. 212
   Google Scholar
• Grant JE, Odlaug BL, Schreiber LR, Kim SW. The opiate antagonist, naltrexone, in the treatment of trichotillomania: results of a double-blind, placebo-controlled study. J Clin Psychopharmacol 2014;34:134-8
   PubMed Web of Science ®Google Scholar
• Grant JE, Odlaug BL, Kim SW. N-Acetylcysteine, a glutamate modulator, in the treatment of trichotillomania: a double-blind, placebo-controlled study. Arch Gen Psychiatry 2009;66:756-63
   PubMed Web of Science ®Google Scholar
• Bloch MH, Panza KE, Grant JE, et al. N-Acetylcysteine in the treatment of pediatric trichotillomania: a randomized, double-blind, placebo-controlled add-on trial. J Am Acad Child Adolesc Psychiatry 2013;52:231-40
   PubMed Web of Science ®Google Scholar
• Grant JE, Odlaug BL, Chamberlain SR, Kim SW. Dronabinol, a cannabinoid agonist, reduces hair pulling in trichotillomania: a pilot study. Psychopharmacology (Berl) 2011;218:493-502
   PubMed Web of Science ®Google Scholar
• Stein DJ, Hollander E. Low-dose pimozide augmentation of serotonin reuptake blockers in the treatment of trichotillomania. J Clin Psychiatry 1992;53:123-6
   PubMed Web of Science ®Google Scholar
• Van Ameringen M, Mancini C, Oakman JM, Farvolden P. The potential role of haloperidol in the treatment of trichotillomania. J Affect Disord 1999;56:219-26
   PubMed Web of Science ®Google Scholar
• Stewart RS, Nejtek VA. An open-label, flexible-dose study of olanzapine in the treatment of trichotillomania. J Clin Psychiatry 2003;64:49-52
   PubMed Web of Science ®Google Scholar
• White MP, Koran LM. Open-label trial of aripiprazole in the treatment of trichotillomania. J Clin Psychopharmacol 2011;31:503-6
   PubMed Web of Science ®Google Scholar
• Van Ameringen M, Mancini C, Patterson B, et al. A randomized, double-blind, placebo-controlled trial of olanzapine in the treatment of trichotillomania. J Clin Psychiatry 2010;71:1336-43
   PubMed Web of Science ®Google Scholar
• Stein DJ, Simeon D, Cohen LJ, Hollander E. Trichotillomania and obsessive-compulsive disorder. J Clin Psychiatry 1995;56:28-34
   PubMed Web of Science ®Google Scholar
• Woods DW, Wetterneck CT, Flessner CA. A controlled evaluation of acceptance and commitment therapy plus habit reversal as a treatment for trichotillomania. Behav Res Ther 2006;44:639-56
   PubMed Web of Science ®Google Scholar
• Walther MR, Snorrason I, Flessner CA, et al. The trichotillomania impact project in young children (TIP-YC): clinical characteristics, comorbidity, functional impairment and treatment utilization. Child Psychiatry Hum Dev 2014;45:24-31
   PubMed Web of Science ®Google Scholar
• Kariuki-Nyuthe C, Gomez-Mancilla B, Stein DJ. Obsessive compulsive disorder and the glutamatergic system. 2014;27:32-7
   Google Scholar
• Müller-Vahl KR, Kolbe H, Schneider U, Emrich HM. Cannabinoids: possible role in patho-physiology and therapy of Gilles de la Tourette syndrome. Acta Psychiatr Scand 1998;98:502-6
   PubMed Web of Science ®Google Scholar
• Müller-Vahl KR, Schneider U, Koblenz A, et al. Treatment of Tourette’s syndrome with Delta 9-tetrahydrocannabinol (THC): a randomized crossover trial. Pharmacopsychiatry 2002;35:57-61
   PubMed Web of Science ®Google Scholar
• Berridge KC, Aldridge JW, Houchard KR, et al. Sequential super-stereotypy of an instinctive fixed action pattern in hyper-dopaminergic mutant mice: a model of obsessive compulsive disorder and Tourette’s. BMC Biol 2005;3:4
   PubMed Web of Science ®Google Scholar
• Korff S, Stein DJ, Harvey BH. Stereotypic behaviour in the deer mouse: pharmacological validation and relevance for obsessive compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2008;32:348-55
   PubMed Web of Science ®Google Scholar
• Woods DW and Houghton DC. Diagnosis, evaluation and management of trichotillomania. Psychiatr Clin North Am 2014;37:301-17
   Google Scholar
• Bate KS, Malouff JM, Thorsteinsson ET, et al. The efficacy of habit reversal therapy for tics, habit disorders, and stuttering: a meta-analytic review. Clin Psychol Rev 2011;31:865-71
   PubMed Web of Science ®Google Scholar